Company: GROVW
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001628280-25-020642
Chunk: 28

Company: Grove Collaborative Holdings, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 28
---
, the stock-price thresholds for vesting were $5.00, $8.00. $12.50 and $21.00 and the performance period applicable to Mr. Yurcisin’s award was five years. In connection with the approval of Mr. Landesberg’s award in February 2024, and in order to increase the retention value of Mr. Yurcisin’s award in light of the market value of our Common Stock, the Compensation Committee changed Mr. Yurcisin’s stock-price vesting thresholds to equal those in the award it approved for Mr. Landesberg. It also changed the performance period for the highest stock price threshold to be five years.

<div align='center'>17</div>

In December 2024, the Compensation Committee granted Mr. Yurcisin RSU awards covering 70,000 shares of Class A Common Stock, consisting of an RSU award covering 30,000 shares of Class A Common Stock that vests quarterly for three years and an RSU covering 40,000 shares of Class A Common Stock that vests approximately one year from the date of grant. These awards were granted to Mr. Yurcisin in connection with the reduction in Mr. Yurcisin’s 2025 base salary from $500,000 to $450,000, which also had the effect of reducing Mr. Yurcisin’s target bonus opportunity for 2025 by an additional $50,000.

Please see the “Outstanding Equity Awards at 2024 Fiscal Year-End” table below for a summary of the equity awards held by the named executive officers as of December 31, 2024.

Equity Grant Procedures

The Company does not grant equity awards in anticipation of the release of material, non-public information.Similarly, the Company does not timethe release of material, non-public information based on equity grant dates for the purpose of affecting the value of any award granted to a named executive officer. The Company also does not take material, non-public information into account when determining the timing and terms of the equity grants. During 2024, none of the named executive officers were granted stock options.

#### Executive Transitions
In December 2024, the Company and Mr. Landesberg agreed that Mr. Landesberg would step down as executive chairperson, effective February 17, 2025 and transition to the role of non-employee member of the Board, initially as chairperson of the Board. In connection with the transition